ICyte Platform March 7, 2022 Unifying IntegriChain’s Services & Support: Customer Support and Value Realization 4 Minute Read In his second unification-focused blog, President and COO Josh Halpern discusses IntegriChain's investment in customer support to better augment the value for customers and end-users.
Market Access Blogs February 28, 2022 Overcoming Drug Commercialization Challenges in Rare Disease 5 Minute Read Solutions to common challenges that manufacturers face when commercializing rare and orphan disease therapies.
Contracts & Pricing February 24, 2022 Branded Pharma Fee: Manufacturer Considerations 5 Minute Read And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.
ICyte Platform February 15, 2022 Unifying IntegriChain’s Services & Support: Data Management 4 Minute Read President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.
Gross-to-Net February 3, 2022 Forecasting for the Future 2 Minute Read How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.
Contracts & Pricing January 24, 2022 New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B 4 Minute Read Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
Corporate January 20, 2022 IntegriChain and Blue Fin Group Combine Forces 2 Minute Read Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.
Launch Readiness January 19, 2022 Best Practices: Redesigning the Perfect Launch 3 Minute Read We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
Channel January 13, 2022 Frequently Asked Questions: Channel and Revenue Leakage 3 Minute Read We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.
